became standard of care and the preferred treatment option in a variety of malignancies: in metastatic melanoma, which is regarded as almost unresponsive to dacarbazine chemotherapy, the Checkmate 066 and 067 trials set a new gold standard for this disease with a 3-year overall survival (OS) rate of 58% in the ipilimumab/nivolumab combination arm [2] . Likewise, in metastatic non-small cell lung cancer (NSCLC) long-term survival can be achieved by immunotherapy. Very recently, the Keynote 189 trial in stage IV nonsquamous NSCLC was presented [3] : It was demonstrated that the new paradigm is not chemotherapy or immunotherapy but both in combination. Chemotherapy plus pembrolizumab results in a 1-year OS rate of nearly 70% [3] . But not only patients suffering from solid tumors benefit from immunotherapy. Adoptive T-cell therapy with socalled CAR T cells revolutionized the treatment of patients with a malignant hematologic disease as well. The Eliana trial demonstrated durable responses in patients suffering from refractory or relapsed acute lymphoblastic leukemia (ALL) [4] .
However, immunotherapy cannot deny its roots and major challenges remain. We still lack a predictive biomarker and it is hardly possible to identify in advance which patients will benefit from immunotherapy. Additionally, novel response patterns such as pseudoprogression were observed and traditional imaging assessment rules are no longer valid for immunotherapy. Furthermore, immune-related adverse events require multidisciplinary management and both health care staff and patient education to prevent severe and potentially lethal side effects. Finally, with the success and broad access of cancer immunotherapy, economic challenges for the public health care systems have arisen.
Taken together, immunotherapy has revolutionized medical oncology and is now the fourth pillar of anti- 82 The adolescence of cancer immunotherapy: from a difficult childhood to a pillar of modern anticancer therapy K editorial cancer treatment, but it still has to transit from adolescence to adulthood in order to unleash its full potential.
